Cytotoxic and Proinflammatory CD8+ T Lymphocytes Promote Development of Vulnerable Atherosclerotic Plaques in ApoE-Deficient Mice

被引:228
|
作者
Kyaw, Tin [1 ,2 ]
Winship, Amy [1 ]
Tay, Christopher [1 ,2 ]
Kanellakis, Peter [1 ]
Hosseini, Hamid [1 ,2 ]
Cao, Anh [2 ]
Li, Priscilla [1 ]
Tipping, Peter [2 ,3 ]
Bobik, Alex [1 ]
Toh, Ban-Hock [2 ]
机构
[1] Baker IDI Heart & Diabet Inst, Vasc Biol & Atherosclerosis Lab, Melbourne, Vic 8008, Australia
[2] Monash Univ, Fac Med Nursing & Hlth Sci, Southern Clin Sch, Ctr Inflammatory Dis,Dept Med, Clayton, Vic 3800, Australia
[3] Prince Henrys Inst Med Res, Clayton, Vic, Australia
基金
英国医学研究理事会;
关键词
CD8+T cells; perforin; granzyme B; vulnerable atherosclerotic plaque; RECEPTOR EXPRESSION; IMMUNE-RESPONSES; GENE-EXPRESSION; CELL-ACTIVATION; TUMOR-NECROSIS; LESIONS; INFLAMMATION; INDUCTION; DENSITY; IDENTIFICATION;
D O I
10.1161/CIRCULATIONAHA.112.001347
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Heart attacks and strokes, leading causes of deaths globally, arise from thrombotic occlusion of ruptured vulnerable atherosclerotic plaques characterized by abundant apoptosis, large necrotic cores derived from inefficient apoptotic cell clearance, thin fibrous caps, and focal inflammation. The genesis of apoptosis and necrotic cores in these vulnerable atherosclerotic plaques remains unknown. Cytotoxic CD8(+) T lymphocytes represent up to 50% of leukocytes in advanced human plaques and dominate early immune responses in mouse lesions, yet their role in atherosclerosis also remains unresolved. 3Methods and Results-CD8(+) T-lymphocyte depletion by CD8 alpha or CD8 beta monoclonal antibody in apolipoprotein E-deficient mice fed a high-fat diet ameliorated atherosclerosis by reducing lipid and macrophage accumulation, apoptosis, necrotic cores, and monocyte chemoattractant protein 1, interleukin 1 beta, interferon gamma, and vascular cell adhesion molecule 1. Transfer of CD8(+) T cells into lymphocyte-deficient, apolipoprotein E-deficient mice partially reconstituted CD8(+) T cells in lymphoid compartments and was associated with CD8(+) T-cell infiltration in lesions, increased lipid and macrophage accumulation, apoptotic cells, necrotic cores, and interleukin 1 beta in atherosclerotic lesions. Transfer of CD8(+) T cells deficient in perforin, granzyme B, or tumor necrosis factor a but not interferon gamma failed to increase atherosclerotic lesions despite partial reconstitution in the lymphoid system and the presence in atherosclerotic lesions. Macrophages, smooth muscle cells, and endothelial cells were identified as apoptotic targets. Conclusions-We conclude that CD8(+) T lymphocytes promote the development of vulnerable atherosclerotic plaques by perforin-and granzyme B-mediated apoptosis of macrophages, smooth muscle cells, and endothelial cells that, in turn, leads to necrotic core formation and further augments inflammation by tumor necrosis factor a secretion. (Circulation. 2013; 127: 1028-1039.)
引用
收藏
页码:1028 / +
页数:23
相关论文
共 50 条
  • [1] Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice
    Fraga-Silva, Rodrigo A.
    Montecucco, Fabrizio
    Costa-Fraga, Fabiana P.
    Nencioni, Alessio
    Caffa, Irene
    Bragina, Maiia E.
    Mach, Francois
    Raizada, Mohan K.
    Santos, Robson A. S.
    da Silva, Rafaela F.
    Stergiopulos, Nikolaos
    VASCULAR PHARMACOLOGY, 2015, 74 : 103 - 113
  • [2] Development of atherosclerotic calcification in apoE-deficient mice
    Shioi, A
    Kizu, A
    Jono, S
    Koyama, H
    Okuno, Y
    Nishizawa, Y
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 151 - 152
  • [3] Telmisartan inhibits biglycan expression in atherosclerotic plaques in ApoE-deficient mice
    Nagy, N.
    Melchior-Becker, A.
    Fischer, J. W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 : 35 - 35
  • [4] Apelin-13 enhances atherosclerotic plaques stability in ApoE-deficient mice
    Fraga-Silva, R. A.
    Seeman, H.
    Montecucco, F.
    da Silva, A. R.
    Burger, F.
    Costa-Fraga, F. P.
    Anguenot, L.
    Mach, F.
    Santos, R. A. S.
    Stergiopulos, N.
    da Silva, R. F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 128 - 128
  • [5] Detection of atherosclerotic plaques in ApoE-deficient mice using 99mTc-duramycin
    Liu, Zhonglin
    Larsen, Brandon T.
    Lerman, Lilach O.
    Gray, Brian D.
    Barber, Christy
    Hedayat, Ahmad F.
    Zhao, Ming
    Furenlid, Lars R.
    Pak, Koon Y.
    Woolfenden, James M.
    NUCLEAR MEDICINE AND BIOLOGY, 2016, 43 (08) : 496 - 505
  • [6] Little role for complement in the development of atherosclerotic lesions in apoE-deficient mice
    Patel, S
    Thelander, E
    Hernandez, M
    Montenegro, J
    Hassing, H
    Burton, C
    Mundt, S
    Chao, YS
    Detmers, PA
    FASEB JOURNAL, 1999, 13 (04): : A283 - A283
  • [7] Overexpression of TGF-β1 in Macrophages Reduces and Stabilizes Atherosclerotic Plaques in ApoE-Deficient Mice
    Reifenberg, Kurt
    Cheng, Fei
    Orning, Carolin
    Crain, Jeanine
    Kuepper, Ines
    Wiese, Elena
    Protschka, Martina
    Blessing, Manfred
    Lackner, Karl J.
    Torzewski, Michael
    PLOS ONE, 2012, 7 (07):
  • [8] Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice
    Park, Tae-Sik
    Rosebury, Wendy
    Kindt, Erick K.
    Kowala, Mark C.
    Panek, Robert L.
    PHARMACOLOGICAL RESEARCH, 2008, 58 (01) : 45 - 51
  • [9] Folic acid supplementation delays atherosclerotic lesion development in apoE-deficient mice
    Carnicer, Ricardo
    Navarro, Maria A.
    Arbones-Mainar, Jose M.
    Acin, Sergio
    Guzman, Mario A.
    Surra, Joaquin C.
    Arnal, Carmen
    Heras, Marcelo de las
    Blanco-Vaca, Francisco
    Osada, Jesus
    LIFE SCIENCES, 2007, 80 (07) : 638 - 643
  • [10] Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice
    Erbel, Christian
    Chen, Lili
    Bea, Florian
    Wangler, Susanne
    Celik, Sultan
    Lasitschka, Felix
    Wang, Ying
    Boeckler, Dittmar
    Katus, Hugo A.
    Dengler, Thomas J.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (12): : 8167 - 8175